Profile: Zeltia SA (ZEL.MC)

ZEL.MC on Madrid SE C.A.T.S.

2.61EUR
11:51am EDT
Price Change (% chg)

€0.05 (+1.76%)
Prev Close
€2.56
Open
€2.61
Day's High
€2.63
Day's Low
€2.58
Volume
179,662
Avg. Vol
413,777
52-wk High
€3.13
52-wk Low
€2.24

Search Stocks
Zeltia SA is a Spain-based holding company primarily engaged, through its subsidiaries, in the chemical and biopharmaceutical sectors. In the biopharmaceutical area its main subsidiaries are: PharmaMar SA, a biopharmaceutical company engaged in the development, production and marketing of marine-based drugs for application in oncology; Noscira SA, which comprises the research and development of drugs for diseases of the nervous system; Genomica SAU, which specializes in molecular diagnostics; and Sylentis SAU, focused on the developing of new therapeutic approaches. In the chemical sector it operates through Zelnova SA, which produces and markets cleaning products for household, industry and gastronomic establishments; and Xylazel SA and Copyr SpA, which are producers of paints, aerosols, varnishes, products for the ecological agriculture, as well as wood and metal protectors for the industrial sector. In May 2014, French subsidiary of PharmaMar SA initiates its commercial activity.

Company Address

Zeltia SA

planta 5
Plaza del Descubridor Diego de O
MADRID   MAD   28003
P: +34914.444500
F: +34915.932954

Search Stocks